192 related articles for article (PubMed ID: 18094950)
1. Target cells in graft-versus-host disease: implications for cancer therapy.
Murphy GF
Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):113-23. PubMed ID: 18094950
[TBL] [Abstract][Full Text] [Related]
2. An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression.
Whitaker-Menezes D; Jones SC; Friedman TM; Korngold R; Murphy GF
Biol Blood Marrow Transplant; 2003 Sep; 9(9):559-70. PubMed ID: 14506658
[TBL] [Abstract][Full Text] [Related]
3. Significance of selectively targeted apoptotic rete cells in graft-versus-host disease.
Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Jun; 10(6):357-65. PubMed ID: 15148489
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cells.
Zhan Q; Korngold R; Lezcano C; McKeon F; Murphy GF
Biol Blood Marrow Transplant; 2012 Jun; 18(6):841-51. PubMed ID: 22469882
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype.
Zhan Q; Signoretti S; Whitaker-Menezes D; Friedman TM; Korngold R; Murphy GF
J Invest Dermatol; 2007 Jan; 127(1):106-15. PubMed ID: 17039241
[TBL] [Abstract][Full Text] [Related]
6. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
Friedman TM; Statton D; Jones SC; Berger MA; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2001; 7(1):2-13. PubMed ID: 11215694
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
8. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease.
Gilliam AC; Whitaker-Menezes D; Korngold R; Murphy GF
J Invest Dermatol; 1996 Sep; 107(3):377-83. PubMed ID: 8751974
[TBL] [Abstract][Full Text] [Related]
10. Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation.
Berrie JL; Kmieciak M; Sabo RT; Roberts CH; Idowu MO; Mallory K; Chung HM; McCarty JM; Borrelli CA; Detwiler MM; Kazim AL; Toor AA; Manjili MH
Transplantation; 2012 May; 93(9):949-57. PubMed ID: 22377792
[TBL] [Abstract][Full Text] [Related]
11. Experimental induction and ultrastructural characterization of apoptosis in murine acute cutaneous graft-versus-host disease.
Yoo YH; Gilliam AC; Whitaker-Menezes D; Korngold R; Murphy GF
Arch Dermatol Res; 1997 Jun; 289(7):389-98. PubMed ID: 9248617
[TBL] [Abstract][Full Text] [Related]
12. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
[TBL] [Abstract][Full Text] [Related]
13. Updating ECP action mechanisms.
Heshmati F
Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
[TBL] [Abstract][Full Text] [Related]
14. Donor Allospecific CD44
Huang W; Mo W; Jiang J; Chao NJ; Chen BJ
Front Immunol; 2019; 10():624. PubMed ID: 31001254
[TBL] [Abstract][Full Text] [Related]
15. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
Ball JA; Clear A; Aries J; Charrot S; Besley C; Mee M; Stagg A; Lindsay JO; Cavenagh J; Calaminci M; Gribben JG; Davies J
Blood; 2021 Feb; 137(5):702-717. PubMed ID: 32905596
[TBL] [Abstract][Full Text] [Related]
17. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
[TBL] [Abstract][Full Text] [Related]
18. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
19. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
